Economic Evaluation of Omalizumab in the Treatment of Severe Allergic Asthma in Adult Patients in Greece: A Cost Effectiveness Analysis of Clinical Trial and Real-Life Data
Keyword(s):
2020 ◽
Vol Volume 13
◽
pp. 43-53
◽